Blog - Page 578 of 5641 - QualityStocks

ThursdayOct 12, 2023 9:00 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) Offers Cybersecurity Suite of Services in the Wake of Increased Dual Ransomware Attacks Worldwide

Dual ransomware attack trends are believed to have begun in early 2022, with two attacks occurring on the same business within a few hours of one another The FBI advises companies to implement migratory procedures and keep detailed, regular backups encrypted, as they are also often targeted Sekur offers a suite of services that include SekurMail, SekurVPN and SekurMessenger without relying on third-party cloud services and offering the highest level of encryption, with information stored in Switzerland Dual ransomware attacks, where a gang attacks the same business twice within a few hours with ransomware, are being flagged by the FBI…

WednesdayOct 11, 2023 1:41 pm

QualityStocksNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Appoints Intel Capital Cofounder to Board

Renovaro BioSciences (NASDAQ: RENB), a biotechnology corporation focusing on cell, gene and immunotherapy, has announced a new member of its board of directors. Avram Miller, cofounder of Intel Capital, will join the board and will also serve in an advisory role, bringing his invaluable experience to contribute to the company's strategy and business development efforts. Miller’s impressive decades-long career includes strategic and responsible roles in both the technology and medical industries. After spending 13 years in the medical science space, he moved to high tech where, in addition to cofounding Intel Capital, he served as the company’s corporate vice president of…

WednesdayOct 11, 2023 1:32 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Rapid Pace of Enrollment in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting enrollment of 229 participants in its ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent GBM, an aggressive and incurable form of brain cancer; the company expects to ultimately enroll 243 in the study. Participants are being enrolled in 46 clinical trial sites across the United States, Italy, France, Spain and Switzerland. According to the announcement, CNS Pharmaceuticals is on track to achieve value-driving milestones before the end of the year, including…

WednesdayOct 11, 2023 12:22 pm

QualityStocksNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) to Host Feasibility Study Conference Call and Webcast

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today announced that it will host a webcast and conference call at 11:00 a.m. Eastern Time on Thursday, Oct. 12, 2023, to discuss the definitive feasibility study for its Crawford Nickel Sulphide Project. Interested parties should visit https://ibn.fm/WYNyd to register for the event and access the webcast and join the call as detailed in the announcement. For those unable to participate, a web-based archive of the conference call will be available for playback at the same Audience URL used to access the live webcast. To view the full press release, visit https://ibn.fm/IrSr4 About Canada…

WednesdayOct 11, 2023 11:27 am

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Receives $1.9M Funding Grant from Canadian Government ACT Program

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, will receive a funding grant of up to $1.9 million through the Research and Innovation Stream of the Agriculture Clean Technology (“ACT”) Program, delivered by Agriculture and Agri-Food Canada (“AAFC”). According to the announcement, the grant was awarded to FuelPositive’s Green NH3 Demonstration Phase Project in support of the commercialization of the FP300 Green Ammonia system. The company noted that it will use the ACT Program funding to gather key information required to continue to adapt its technology to the commercial needs…

WednesdayOct 11, 2023 10:30 am

The 18th BioPharma Drug Discovery Nexus: Innovation in Life Sciences

Large, mid-size, and small pharma companies, are invited to attend the 18th Biopharma Drug Discovery Nexus being held October 17-18, 2023, in Philadelphia. As the countdown for this prestigious event begins, the world is set to witness the innovative benchmarks in the realm of life sciences and drug discovery. The 18th edition of this event will serve as an incredible platform for advanced technologies, groundbreaking research, and collaborative discussions. The BioPharma Drug Discovery Nexus has long been synonymous with technological advancement in the life sciences industry. The popular event will bring together specialists and thought leaders from across the pharmaceutical…

WednesdayOct 11, 2023 9:45 am

Electronic Servitor Publication Network Inc. (XESP) is Reinventing How Marketers and Companies Digitally Connect with Target Markets

Electronic Servitor Publication Network, helping B2B companies use smart technology to reach target markets, is focused on eliminating wastefulness, driving growth, and spawning modern businesses that can navigate the ever-evolving digital world The company has developed the revolutionary Digital Engagement Engine(TM), which combines cutting-edge data analysis, a technology stack that can identify even the narrowest of niches within a target market, tailored content, and precision delivery The platform expands and creates increased reach to new communities and preserves existing reach by nurturing audiences and creating genuine interest The Digital Engagement Engine(TM) and other smart technologies are shaping the future of…

WednesdayOct 11, 2023 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) to Showcase Trademarked REE Separation Process Details in Canadian Autotech Program, U.S. Defense Department Project

Ucore Rare Metals Inc. is devoted to improving the supply chain for rare earth elements (“REEs”) through commercialization of its trademarked RapidSX(TM) technology REEs are in high demand for modern computer applications that use the metallic products in high-grade batteries, motors, speakers and hard drives China effectively dominates the industries that produce and process REEs, leading U.S. and Canadian governments to prioritize a China-independent supply chain for the critical technology Ucore has been demonstrating the advantages of its RapidSX(TM) technology over standard SX ore separation technology at the company’s Ontario, Canada test facility The company will present information on its…

TuesdayOct 10, 2023 2:28 pm

QualityStocksNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Strategic Board Appointments of Two Finance Industry Experts

Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, today announced the appointment of Leni Boeren and Ruud Hendriks as independent directors. Both Boeren and Hendriks bring extensive, high-level experience in finance and business. Boeren has a 40-year career in the financial sector, commencing with banking roles at Paribas and Rabobank before holding several director-level positions at Amsterdam exchanges and then Euronext. Hendriks brings more than 35 years of experience in the asset management industry, having held senior roles at some of the most established financial institutions.…

TuesdayOct 10, 2023 2:21 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) to Serve as Gold Sponsor of Synchrony Symposia 2023

PaxMedica (NASDAQ: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions, today announced its Gold Sponsorship of The BRAIN Foundation's esteemed Synchrony Symposia 2023. The globally recognized event serves as a catalyst for translational research in autism and related neurodevelopmental disorders and brings together leading scientists, clinicians, biotech and pharmaceutical companies, venture partners, and community stakeholders to foster scientific advancements that can enhance the well-being and quality of life for individuals affected by ASD. “We are honored to support The BRAIN…

Site Search

Company Search